Answers are grounded in this paper and cite their sources.
The fourth version of Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by the Japan Society of Hepatology, according to the methodology of evidence-based medicine and partly to the Grading of Recommendations Assessment, Development, and Evaluation system, which was published in October 2017 in Japanese. New or revised recommendations were described, herein, with a special reference to the surveillance, diagnostic, and treatment algorithms.
No takes yet. Share an insight, caveat, or question.
Kokudo et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: